Profile
Michael C.
Venuti was the founder of Agua Enerviva LLC, which was founded in 2012, where he held the title of President from 2012 to 2020.
He also held former positions as Chief Executive Officer & Director at Discovery Partners International, Inc., Chief Executive Officer & Director at BioSeek, Inc. from 2007 to 2010, President, Chief Executive Officer & Director at iPierian, Inc. from 2010 to 2011, Chief Executive Officer at Willow Neuroscience, Inc., Director-Bioorganic Chemistry at Genentech, Inc. from 1993 to 1993, Independent Director at Infinity Pharmaceuticals, Inc. from 2003 to 2020, Senior Vice President-Research & Development at Axys Pharmaceuticals, Inc. from 1994 to 2001, Chief Technical Officer at Arris Pharmaceutical Corp.
in 2001, Senior Vice President-Research at Celera Group, and Chief Scientific Officer at NeuroTherapeutics Pharma, Inc. from 2011 to 2013.
Dr. Venuti's education history includes an undergraduate degree from Dartmouth College and a doctorate degree from Massachusetts Institute of Technology, which was conferred in 1979.
Former positions of Michael C. Venuti
Companies | Position | End |
---|---|---|
INFINITY PHARMACEUTICALS, INC. | Director/Board Member | 12/11/2020 |
Agua Enerviva LLC
Agua Enerviva LLC Beverages: Non-AlcoholicConsumer Non-Durables Agua Enerviva LLC produces energy drinks. It offers its products through online retailers. The firm’s products include Agua active hydration and fruit essence. The company was founded by Carol Dollard and Michael C. Venuti in 2012 and is headquartered in Bethpage, NY. | Founder | 12/11/2020 |
Willow Neuroscience, Inc.
Willow Neuroscience, Inc. Medical DistributorsDistribution Services Willow Neuroscience, Inc. operates as a biotechnology company that wholesales pharmaceutical products. The company is headquartered in Emeryville, CA. | Chief Executive Officer | 12/11/2020 |
NeuroTherapeutics Pharma, Inc.
NeuroTherapeutics Pharma, Inc. Pharmaceuticals: MajorHealth Technology NeuroTherapeutics Pharma, Inc. is a biopharmaceutical company focused on developing therapies for diseases associated with central nervous system hyper-excitability. It is developing compounds that decrease or eliminate aberrant excitatory discharges by working through a new mechanism of action. The firm's proprietary molecules target a novel molecular site that will create a pipeline of potential new treatments for multiple CNS disorders. The company's lead compound, NTP-2014, has exhibited excellent efficacy results in multiple preclinical models of epilepsy, acute and neuropathic pain. NeuroTherapeutics Pharma was founded in 2006 and is headquartered in Chicago, IL. | Chief Tech/Sci/R&D Officer | 01/06/2013 |
iPierian, Inc.
iPierian, Inc. Pharmaceuticals: MajorHealth Technology ierian, Inc. developed and manufactured biopharmaceutical products. The firm's lead antibody, IPN007, represents a new approach to treating neurodegenerative disease by targeting a novel form of secreted Tau protein. The company was founded in 2007 and is headquartered in South San Francisco, CA. | Chief Executive Officer | 01/04/2011 |
Training of Michael C. Venuti
Massachusetts Institute of Technology | Doctorate Degree |
Dartmouth College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
INFINITY PHARMACEUTICALS, INC. | Health Technology |
Private companies | 11 |
---|---|
BioSeek, Inc.
BioSeek, Inc. Miscellaneous Commercial ServicesCommercial Services BioSeek, an Asterand company, is improving the success rate of pharmaceutical research and development by integrating human biology from the earliest stages of drug discovery onward. Their BioMAP® Systems incorporate predictive primary human cell-based disease models that generate uniquely informative biological activity profiles for each potential drug. As a result, their technology drives the selection and development of new drug candidates. they leverage their BioMAP® Systems technology in collaborations to enhance the productivity of their pharmaceutical partners' pipelines to identify promising compounds for therapeutic development. Asterand plc acquired BioSeek on February 18, 2010. Asterand is the leading global supplier of high quality, well characterized human tissue and human tissue-based research services to drug discovery scientists. BioSeek's BioMAP® platform and primary human cell based assays are highly complementary to the human tissue-based products and services offered by Asterand. Formed in January 2006 from the merger of Asterand, a human tissue biorepository, and Pharmagene, a human tissue-based drug discovery company, Asterand plc is uniquely positioned to provide a comprehensive approach to meet the research needs of pharmaceutical and biotechnology companies. From their offices in Royston (United Kingdom), San Francisco, California and Detroit, Michigan they have more than 90 employees focused on providing services and products to accelerate drug discovery research from target identification through to compound evaluation and drug safety. | Commercial Services |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Health Technology |
Arris Pharmaceutical Corp. | Commercial Services |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
iPierian, Inc.
iPierian, Inc. Pharmaceuticals: MajorHealth Technology ierian, Inc. developed and manufactured biopharmaceutical products. The firm's lead antibody, IPN007, represents a new approach to treating neurodegenerative disease by targeting a novel form of secreted Tau protein. The company was founded in 2007 and is headquartered in South San Francisco, CA. | Health Technology |
TPG Growth LLC
TPG Growth LLC Investment ManagersFinance TPG Growth LLC is a Venture Capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2000 by William E. McGlashan and Michael Guthrie. The firm is headquartered in San Francisco, United States with additional office in London, United Kingdom. | Finance |
NeuroTherapeutics Pharma, Inc.
NeuroTherapeutics Pharma, Inc. Pharmaceuticals: MajorHealth Technology NeuroTherapeutics Pharma, Inc. is a biopharmaceutical company focused on developing therapies for diseases associated with central nervous system hyper-excitability. It is developing compounds that decrease or eliminate aberrant excitatory discharges by working through a new mechanism of action. The firm's proprietary molecules target a novel molecular site that will create a pipeline of potential new treatments for multiple CNS disorders. The company's lead compound, NTP-2014, has exhibited excellent efficacy results in multiple preclinical models of epilepsy, acute and neuropathic pain. NeuroTherapeutics Pharma was founded in 2006 and is headquartered in Chicago, IL. | Health Technology |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Health Technology |
Discovery Partners International, Inc.
Discovery Partners International, Inc. Miscellaneous Commercial ServicesCommercial Services Discovery Partners International, Inc. (DPI) used to research laboratory looking to discovery pharmaceutical products. It was a small molecule and natural product based drug discovery company that offered collaborations and services complementing the internal capabilities of pharmaceutical and biopharmaceutical. Discovery Partners has actively contributed to dozens of drug discovery collaborations. The company had operations in United States and Europe. The company was founded in 1995 was headquartered in San Diego, CA | Commercial Services |
Agua Enerviva LLC
Agua Enerviva LLC Beverages: Non-AlcoholicConsumer Non-Durables Agua Enerviva LLC produces energy drinks. It offers its products through online retailers. The firm’s products include Agua active hydration and fruit essence. The company was founded by Carol Dollard and Michael C. Venuti in 2012 and is headquartered in Bethpage, NY. | Consumer Non-Durables |
Willow Neuroscience, Inc.
Willow Neuroscience, Inc. Medical DistributorsDistribution Services Willow Neuroscience, Inc. operates as a biotechnology company that wholesales pharmaceutical products. The company is headquartered in Emeryville, CA. | Distribution Services |
- Stock Market
- Insiders
- Michael C. Venuti